Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Accured Expenses (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Change in Accured Expenses for 16 consecutive years, with $141000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 115.08% to $141000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.5 million through Dec 2025, up 59.12% year-over-year, with the annual reading at -$1.5 million for FY2025, 59.12% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $141000.0 at Anika Therapeutics, down from $3.6 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $4.6 million in Q3 2023, with the low at -$4.3 million in Q2 2023.
  • Average Change in Accured Expenses over 5 years is -$22700.0, with a median of $273500.0 recorded in 2021.
  • The sharpest move saw Change in Accured Expenses skyrocketed 287.22% in 2021, then plummeted 567.67% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $406000.0 in 2021, then plummeted by 237.44% to -$558000.0 in 2022, then surged by 231.54% to $734000.0 in 2023, then tumbled by 227.38% to -$935000.0 in 2024, then soared by 115.08% to $141000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $141000.0, $3.6 million, and -$2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.